https://www.selleckchem.com/pr....oducts/apr-246-prima
Coronary no-reflow phenomenon (CNP) is associated with an increased risk of major cardiovascular adverse events (MACE). This study aimed to evaluate the relationship between serum Kidney Injury Molecule-1 (KIM-1) levels and CNP in patients with acute ST-segment elevation myocardial infarction (STEMI). This study included a total of 160 patients (113 males and 47 females; mean age 61.65±12.14 years) who were diagnosed with STEMI. The patients were divided into two groups, the reflow group (RG) (n=14 and the no-reflow group (
Like
Comment
Share
